Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

IONIS PHARMACEUTICALS INC (IONS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q8-K10-K10-Q10-Q10-Q10-K10-Q
Revenue:          
Revenue  188.4131.0151.9159.8133.8141.9440.0133.1
            Revenue growth  40.8%-7.7%-65.5%20.0%6.4%27.2%51.6%-16.9%
Expenses:          
Cost of sales  2.5 3.71.54.74.22.23.1
Research, development and patent  229.9198.0308.3183.0180.8161.1179.6184.8
Selling, general and administrative  46.146.048.034.433.834.137.631.1
    Total operating expenses  278.6246.0359.9218.9219.3199.4219.4218.9
    Loss from operations  -90.2-114.0-208.0-59.2-85.5-57.5220.6-85.8
            Operating margin  -47.9%-87.0%-137.0%-37.0%-63.9%-40.5%50.1%-64.5%
   
Other income (expense):          
Investment income  20.8 11.97.53.42.01.80.9
Interest expense  -2.3 -1.7-2.1-2.1-2.1-2.2-2.3
Interest expense related to sale of future royalties  -17.7       
Gain (loss) on investments  0.7 3.32.3-6.3-6.65.24.0
Other income (expense)  11.217.00.64.7-12.30.2-0.5-0.5
    Loss before income tax expense  -77.4 -44.3-46.7-102.9-64.1224.9-83.8
Income tax expense  -7.8-11.0-8.1-0.3-2.3-1.1-0.31.3
    Net loss  -85.3-124.0-52.4-47.0-105.1-65.2224.6-82.5
   
Basic net loss per share (in dollars per share)  ($0.60)($0.87)($0.37)($0.33)($0.74)($0.46)$1.60($0.58)
Diluted net loss per share (in dollars per share)  ($0.60)($0.87)($0.37)($0.33)($0.74)($0.46)$1.60($0.58)
   
Shares used in computing basic net loss per share (in shares)  143.1143.0141.8142.0141.8141.6141.0141.1
Shares used in computing diluted net loss per share (in shares)  143.1143.0141.8142.0141.8141.6141.0141.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy